BDX Becton, Dickinson and Company
Stock · NYSE · United States · Healthcare · US0758871091
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Becton, Dickinson and Company, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:50. Information, not advice.
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Feb 2027 08:00 | 2.73 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 4.07 | 4.15 | +2.0% | Beat |
| 06 Aug 2026 06:00 | 3.14 | 3.23 | +2.9% | Beat |
| 07 May 2026 06:00 | 2.77 | 2.90 | +4.5% | Beat |
| 09 Feb 2026 06:00 | 2.80 | 2.91 | +3.9% | Beat |
| 06 Nov 2025 06:00 | 3.91 | 3.96 | +1.2% | Beat |
| 07 Aug 2025 06:00 | 3.40 | 3.68 | +8.2% | Beat |
| 01 May 2025 06:00 | 3.28 | 3.35 | +2.1% | Beat |
| 05 Feb 2025 16:00 | 2.99 | 3.43 | +14.7% | Beat |
| 07 Nov 2024 06:00 | 3.77 | 3.81 | +1.1% | Beat |
| 01 Aug 2024 06:00 | 3.31 | 3.50 | +5.8% | Beat |
| 02 May 2024 06:00 | 2.97 | 3.17 | +6.8% | Beat |
| 01 Feb 2024 06:00 | 2.40 | 2.68 | +11.6% | Beat |
| 09 Nov 2023 06:00 | 3.43 | 3.42 | -0.2% | In line |
| 03 Aug 2023 06:00 | 2.91 | 2.96 | +1.6% | Beat |
| 04 May 2023 06:00 | 2.75 | 2.86 | +4.0% | Beat |
| 02 Feb 2023 06:00 | 2.68 | 2.98 | +11.0% | Beat |
| 10 Nov 2022 06:00 | 2.74 | 2.75 | +0.4% | In line |
| 04 Aug 2022 06:00 | 2.50 | 2.66 | +6.5% | Beat |
| 05 May 2022 06:00 | 2.95 | 3.18 | +7.9% | Beat |
| 03 Feb 2022 06:00 | 2.85 | 3.64 | +27.5% | Beat |
| 04 Nov 2021 06:00 | 2.45 | 2.59 | +5.5% | Beat |
| 05 Aug 2021 06:00 | 2.44 | 2.74 | +12.2% | Beat |
| 06 May 2021 06:00 | 3.04 | 3.19 | +5.1% | Beat |
| 04 Feb 2021 06:00 | 3.16 | 4.55 | +43.8% | Beat |
| 05 Nov 2020 06:00 | 2.54 | 2.79 | +10.0% | Beat |
| 06 Aug 2020 06:00 | 2.07 | 2.20 | +6.3% | Beat |
| 07 May 2020 07:00 | 2.29 | 2.55 | +11.4% | Beat |
| 06 Feb 2020 06:00 | 2.64 | 2.65 | +0.3% | In line |
| 05 Nov 2019 06:00 | 3.31 | 3.31 | +0.1% | In line |
| 06 Aug 2019 06:00 | 3.06 | 3.08 | +0.8% | In line |
| 09 May 2019 06:00 | 2.59 | 2.59 | -0.2% | In line |
| 05 Feb 2019 06:00 | 2.62 | 2.70 | +3.2% | Beat |
| 06 Nov 2018 06:00 | 2.93 | 2.93 | +0.0% | In line |
| 02 Aug 2018 06:00 | 2.86 | 2.91 | +1.7% | Beat |
| 03 May 2018 06:00 | 2.63 | 2.65 | +0.9% | In line |
| 06 Feb 2018 06:00 | 2.41 | 2.48 | +3.0% | Beat |
| 02 Nov 2017 06:00 | 2.37 | 2.40 | +1.1% | Beat |
| 03 Aug 2017 06:00 | 2.44 | 2.46 | +0.8% | In line |
| 02 May 2017 06:00 | 2.23 | 2.30 | +2.9% | Beat |
| 02 Feb 2017 06:00 | 2.11 | 2.33 | +10.3% | Beat |
| 03 Nov 2016 06:00 | 2.07 | 2.12 | +2.3% | Beat |
| 04 Aug 2016 06:00 | 2.20 | 2.35 | +6.9% | Beat |
| 05 May 2016 06:00 | 2.01 | 2.18 | +8.2% | Beat |
| 03 Feb 2016 06:00 | 1.84 | 1.96 | +6.3% | Beat |
| 04 Nov 2015 06:00 | 1.90 | 1.94 | +2.1% | Beat |
| 06 Aug 2015 06:00 | 2.01 | 2.05 | +2.2% | Beat |
| 07 May 2015 06:00 | 1.53 | 1.61 | +5.1% | Beat |
| 05 Feb 2015 06:00 | 1.44 | 1.53 | +6.4% | Beat |
| 04 Nov 2014 06:00 | 1.66 | 1.68 | +1.5% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 21.8B | +8.2% | 1.7B | 7.7% | 5.82 | -1.9% | 2.7B |
| 2024 | 20.2B | +4.2% | 1.7B | 8.4% | 5.93 | +20.0% | 3.1B |
| 2023 | 19.4B | +2.7% | 1.5B | 7.7% | 4.94 | -16.0% | 2.1B |
| 2022 | 18.9B | — | 1.8B | 9.4% | 5.88 | — | 1.7B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 22 Jan 2026 | 161.99 | 163.21 | 160.60 | 161.98 | -0.07% | 2,573,383 | |
| 21 Jan 2026 | 161.22 | 163.16 | 160.48 | 162.09 | +1.37% | 2,216,587 | |
| 20 Jan 2026 | 160.99 | 162.22 | 159.69 | 159.90 | -1.80% | 2,000,347 | |
| 16 Jan 2026 | 162.80 | 164.40 | 162.46 | 162.82 | -0.60% | 2,022,989 | |
| 15 Jan 2026 | 162.37 | 164.52 | 161.61 | 163.80 | +0.45% | 2,761,512 | |
| 14 Jan 2026 | 158.66 | 163.24 | 157.87 | 163.07 | +2.93% | 1,835,242 | |
| 13 Jan 2026 | 159.32 | 160.10 | 156.01 | 158.43 | -0.60% | 1,473,485 | |
| 12 Jan 2026 | 159.43 | 160.04 | 158.29 | 159.39 | 0.00% | 1,757,141 | |
| 09 Jan 2026 | 161.93 | 162.24 | 158.33 | 159.39 | -1.18% | 1,680,694 | |
| 08 Jan 2026 | 158.25 | 162.73 | 158.25 | 161.31 | +1.22% | 1,819,087 | |
| 07 Jan 2026 | 161.48 | 162.63 | 158.82 | 159.36 | -1.29% | 2,611,289 | |
| 06 Jan 2026 | 155.87 | 162.04 | 155.80 | 161.45 | +3.22% | 2,598,823 | |
| 05 Jan 2026 | 152.61 | 157.85 | 152.20 | 156.42 | +2.06% | 2,942,518 | |
| 02 Jan 2026 | 152.74 | 153.92 | 151.32 | 153.25 | +0.45% | 1,734,754 | |
| 31 Dec 2025 | 153.72 | 154.12 | 152.55 | 152.57 | -0.80% | 999,919 | |
| 30 Dec 2025 | 153.15 | 154.23 | 152.96 | 153.81 | +0.25% | 974,352 | |
| 29 Dec 2025 | 154.25 | 154.47 | 152.96 | 153.43 | -0.60% | 1,542,046 | |
| 26 Dec 2025 | 154.15 | 155.06 | 153.20 | 154.35 | +0.11% | 1,292,606 | |
| 24 Dec 2025 | 154.09 | 154.65 | 153.50 | 154.18 | +0.23% | 544,670 | |
| 23 Dec 2025 | 154.37 | 154.37 | 153.16 | 153.83 | -0.54% | 1,323,389 | |
| 22 Dec 2025 | 154.15 | 155.74 | 153.99 | 154.67 | +0.59% | 1,923,391 | |
| 19 Dec 2025 | 152.75 | 154.72 | 152.59 | 153.77 | +0.46% | 6,338,376 | |
| 18 Dec 2025 | 153.38 | 154.86 | 152.73 | 153.07 | -0.34% | 4,222,277 | |
| 17 Dec 2025 | 154.11 | 156.04 | 153.27 | 153.58 | -0.52% | 4,210,702 | |
| 16 Dec 2025 | 157.41 | 157.87 | 153.40 | 154.39 | -1.85% | 3,025,706 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- How Investors Are Reacting To BD Stock After An Earnings Beat (opens in a new tab) Simply Wall St. · 06 Nov 2026 18:15
- Citigroup Maintains Buy on Becton Dickinson, Raises Price Target to $241 (opens in a new tab) Benzinga · 06 Nov 2026 17:46
- RBC Capital Maintains Sector Perform on Becton Dickinson, Raises Price Target to $225 (opens in a new tab) Benzinga · 06 Nov 2026 14:00
- Buy, Sell, or Hold? Friday’s Top Upgrades and Downgrades: Becton Dickinson, BJ’s Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More (opens in a new tab) 24/7 Wall St. · 06 Nov 2026 13:00
- 3 Stocks in Focus That Hiked Dividends Amid Ongoing Market Volatility (opens in a new tab) Zacks · 06 Nov 2026 12:31
- Becton, Dickinson and Company Q4 Earnings Call Highlights (opens in a new tab) MarketBeat · 06 Nov 2026 12:14
- Evercore ISI Group Maintains Outperform on Becton Dickinson, Raises Price Target to $230 (opens in a new tab) Benzinga · 06 Nov 2026 10:37
- Piper Sandler Maintains Neutral on Becton Dickinson, Raises Price Target to $200 (opens in a new tab) Benzinga · 06 Nov 2026 10:20
- Wells Fargo Upgrades Becton Dickinson to Overweight, Raises Price Target to $242 (opens in a new tab) Benzinga · 06 Nov 2026 08:48
- Becton Dickinson & Co (BDX) (Q4 2026) Earnings Call Highlights: Strong Q4 Beat, $19 Billion ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 03:15
- Becton, Dickinson and Company Q4 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 22:55
- Becton Dickinson (BDX) Q4 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 21:03
- Becton Dickinson, Cardinal Health Beat Quarterly Views (opens in a new tab) MT Newswires · 05 Nov 2026 17:55
- BD reports FY26 revenues of $19.5bn after medtech prioritisation (opens in a new tab) Medical Device Network · 05 Nov 2026 16:58
- BDX Stock Down in Pre-Market Despite Q4 Earnings & Revenue Beat (opens in a new tab) Zacks · 05 Nov 2026 16:45
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 213.55 USD
- Market cap
- 57.7B
- Dividend yield
- 2.00%
- 5-year average yield
- 1.66%
- Payout ratio
- 72%
- Last dividend
- 1.0500 USD · 10 Dec 2026
- Next ex-dividend date
- 10 Dec 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 09 Sep 2026 | 1.0500 USD |
| 09 Jun 2026 | 1.0500 USD |
| 10 Mar 2026 | 1.0500 USD |
| 08 Dec 2025 | 0.8255 USD |
| 08 Sep 2025 | 0.8176 USD |
| 09 Jun 2025 | 0.8176 USD |
| 10 Mar 2025 | 0.8176 USD |
| 09 Dec 2024 | 0.8176 USD |
| 09 Sep 2024 | 0.7469 USD |
| 10 Jun 2024 | 0.7469 USD |
| 07 Mar 2024 | 0.7469 USD |
| 07 Dec 2023 | 0.7469 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 8.3 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 16.6 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 13.8 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 6.4 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 6.3 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 0.4 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 41.87× | Weak | 30.65× |
| P/E (forward) | 14.94× | Good | 14.89× |
| Price / book | 2.34× | Fair | 3.8× |
| Price / sales | 2.97× | Fair | 3.19× |
| EV / EBITDA | 13.89× | Fair | 12.61× |
| Free cash flow yield | 7.2% | Good | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 47% | Good | 58.6% |
| Operating margin | 21.6% | Good | 7.6% |
| Net margin | 5.9% | Fair | 2.7% |
| Return on equity | 5.7% | Weak | 5.7% |
| Return on assets | 3.6% | Fair | 3.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 5% | Fair | 10.8% |
| EPS growth / year | -0.3% | Weak | 9.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.66× | Good | 0.48× |
| Net debt / EBITDA | 2.95× | Fair | 1.6× |
| Interest cover | 4.87× | Fair | 2.65× |
| Current ratio | 0.87× | Weak | 2.36× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 72.5% | Weak | 0% |
| Payout of free cash flow | 28.9% | Good | 28.8% |
| Payout of free cash flow (3 years) | 43.4% | Good | — |
| Dividend growth / year | 6.7% | Good | 7.1% |
| Years of rising dividends | 13 | Good | 2 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow BDX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.